Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
about
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.Long-term impact of behavioral weight loss intervention on cognitive functionTreatment of affective disorders in cardiac diseaseClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsBrain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.Relative differences in resting-state brain connectivity associated with long term intensive lifestyle intervention.Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial.Impact of a Multidomain Intensive Lifestyle Intervention on Complaints About Memory, Problem-Solving, and Decision-Making Abilities: The Action for Health in Diabetes Randomized Controlled Clinical Trial
P2860
Q27687851-8EB2F303-6D09-45CE-85F7-C61ED83639E2Q34073450-7B7A9B04-D79F-4F3F-A5D2-132086F8DC8AQ34152622-F3577170-2524-4DD1-A999-42C7C278D19BQ35899447-CAD80D1A-B482-4069-9E85-D002827CD85AQ37011769-B7828FB5-5FAC-46D4-8CE3-670A11AE1835Q37586430-99E367C1-C96D-47BD-BA71-686FFBF3C774Q38377477-D9C2EFEF-66BF-4CE9-8291-5956B653C72CQ38816454-9EC80DF8-3E57-42D0-84D1-428BD99C6A24Q40715268-BDA9DB06-BC46-4063-80C9-2FB05054A783Q47159617-21BE9443-A362-44EB-AEED-A1A3E64706ECQ51816129-0E4E3E15-627E-4DB4-BE0B-C5DC6E6996CEQ57294832-C9DEE2E5-23D5-45C1-9568-47FF3D103EFC
P2860
Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Four-year analysis of cardiova ...... al of weight loss in diabetes.
@en
type
label
Four-year analysis of cardiova ...... al of weight loss in diabetes.
@en
prefLabel
Four-year analysis of cardiova ...... al of weight loss in diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
Four-year analysis of cardiova ...... al of weight loss in diabetes.
@en
P2093
Don Williamson
Gina Evans-Hudnall
Linda Ewing
Lucy F Faulconbridge
Mark Peyrot
Richard R Rubin
Sarah A Gaussoin
P2860
P304
P356
10.2337/DC12-1871
P407
P50
P577
2013-01-28T00:00:00Z